NRXS

Neuraxis (NRXS)

Neuraxis Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:AMEX:NRXS

1 2 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/07	22:00	GlobeNewswire Inc.	NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure	AMEX:NRXS	Neuraxis Inc
2024/05/22	21:00	GlobeNewswire Inc.	NeurAxis Reports First Quarter 2024 Financial Results	AMEX:NRXS	Neuraxis Inc
2024/05/21	22:00	GlobeNewswire Inc.	NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024	AMEX:NRXS	Neuraxis Inc
2024/05/21	05:18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:NRXS	Neuraxis Inc
2024/05/16	22:00	GlobeNewswire Inc.	NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida	AMEX:NRXS	Neuraxis Inc
2024/05/16	05:30	GlobeNewswire Inc.	NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024	AMEX:NRXS	Neuraxis Inc
2024/05/16	05:15	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	AMEX:NRXS	Neuraxis Inc
2024/04/23	22:00	GlobeNewswire Inc.	NeurAxis Announces New Medical Policy Coverage in North Dakota	AMEX:NRXS	Neuraxis Inc
2024/04/10	05:05	GlobeNewswire Inc.	NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results	AMEX:NRXS	Neuraxis Inc
2024/04/02	05:15	GlobeNewswire Inc.	NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024	AMEX:NRXS	Neuraxis Inc
2024/03/27	22:00	GlobeNewswire Inc.	NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry	AMEX:NRXS	Neuraxis Inc
2024/03/11	22:00	GlobeNewswire Inc.	NeurAxis Announces Highmark BCBS Policy Coverage	AMEX:NRXS	Neuraxis Inc
2024/03/11	21:50	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NRXS	Neuraxis Inc
2024/03/04	23:00	GlobeNewswire Inc.	NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage	AMEX:NRXS	Neuraxis Inc
2024/02/28	01:00	GlobeNewswire Inc.	NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference	AMEX:NRXS	Neuraxis Inc
2024/02/16	07:00	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NRXS	Neuraxis Inc
2024/01/31	23:15	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NRXS	Neuraxis Inc
2023/12/20	23:00	GlobeNewswire Inc.	NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer	AMEX:NRXS	Neuraxis Inc
2023/12/20	07:05	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	AMEX:NRXS	Neuraxis Inc
2023/12/20	07:00	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NRXS	Neuraxis Inc
2023/11/21	07:30	GlobeNewswire Inc.	NeurAxis Reports Third Quarter 2023 Financial Results	AMEX:NRXS	Neuraxis Inc
2023/11/21	07:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:NRXS	Neuraxis Inc
2023/11/15	23:00	GlobeNewswire Inc.	NeurAxis Announces CareFirst BCBS Policy Coverage	AMEX:NRXS	Neuraxis Inc
2023/11/14	23:00	GlobeNewswire Inc.	NeurAxis Secures $3 Million Financing	AMEX:NRXS	Neuraxis Inc
2023/11/08	23:00	GlobeNewswire Inc.	NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device	AMEX:NRXS	Neuraxis Inc
2023/09/26	22:00	GlobeNewswire Inc.	NeurAxis Announces Results of Comparative Study of IB-Stim™ and Standard Medical Therapy in Adolescents with Functional Abdominal Pain Disorders	AMEX:NRXS	Neuraxis Inc
2023/09/23	05:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:NRXS	Neuraxis Inc
2023/09/21	21:30	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:NRXS	Neuraxis Inc
2023/09/21	21:00	GlobeNewswire Inc.	NeurAxis Reports Second Quarter 2023 Financial Results	AMEX:NRXS	Neuraxis Inc
2023/09/14	05:15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:NRXS	Neuraxis Inc